All lobbying filings
Goodrx, Inc.
Goodrx, Inc. filed a Q1 report for Goodrx, Inc. on April 20, 2026.
Lobbying for Goodrx, Inc.
Filing · LD-2 quarterly report
Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Expenses
$370,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
California
Government bodies contacted
2
Lobbying activity
2
-Issues regarding prescription drug pricing. -Issues regarding telehealth.
Monitoring federal legislation and outreach to congressional offices.